D-1251-2019 Class II Terminated
FDA drug recall D-1251-2019 was initiated by Advanced Pharma Inc. on Apr 26, 2019 and is designated Class II. Reason for recall: Sub-potency The recall status is terminated (terminated Oct 30, 2019). Affected quantity: 560 bags.
Recall details
- Product Type
- Drugs
- Report Date
- May 8, 2019
- Initiation Date
- Apr 26, 2019
- Termination Date
- Oct 30, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 560 bags
Product description
HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, Sterile single use bag, Compounded Drug, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC: 42852-221-10
Reason for recall
Sub-potency
Distribution pattern
Nationwide in the US
Code information
Lot: 01/14/19 0215 22110P Exp. 04/29/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1251-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026